best acute myeloid leukemia treatment in india
Services
make an appointment
BMT Next is a premier destination for acute myeloid leukemia (AML) treatment in India, offering a complete range of diagnostic and therapeutic services including bone marrow transplant for AML, targeted therapy, and supportive care. As one of the best AML treatment centers in India and Mauritius, we combine medical excellence with affordability. Patients across India and Mauritius trust BMT Next for life-saving treatment options tailored to all risk categories including high-risk, refractory, and relapsed AML.
Best Acute Myeloid Leukemia (AML) Treatment in India
Acute myeloid leukemia (AML) is an aggressive blood and bone marrow cancer marked by rapid progression. It arises when the bone marrow produces abnormal myeloid cells that fail to mature properly. Symptoms typically include persistent fatigue, infections, unexplained bruising or bleeding, fever, and weight loss. AML must be diagnosed and treated urgently to prevent life-threatening complications.
At BMT Next, we conduct a detailed workup that includes blood smear, bone marrow biopsy, cytogenetics, flow cytometry, and next-generation sequencing (NGS) to determine AML subtype and genetic mutations like FLT3, NPM1, IDH1, IDH2, and TP53. This guides us in developing a personalized treatment plan.
Acute Myeloid Leukemia (AML) Treatment Options
Our approach to AML treatment is built around patient-specific risk classification, disease genetics, age, fitness, and treatment goals. All treatments follow global best practices, including ELN and NCCN guidelines.
Induction Chemotherapy for Acute Myeloid Leukemia (AML)
The first step in acute myeloid leukemia treatment is to induce remission using induction chemotherapy. BMT Next offers standard 7+3 therapy (cytarabine and daunorubicin) for most patients. For those who relapse or present with adverse features, we use FLAG-IDA or high-dose cytarabine regimens. Older or unfit patients are managed with venetoclax in combination with hypomethylating agents.
Targeted Therapy in AML
For patients with molecular mutations, we provide FDA-approved targeted therapies including midostaurin and gilteritinib for FLT3-mutant AML, as well as ivosidenib and enasidenib for IDH1 and IDH2 mutations. These therapies are essential in improving response rates and extending remission durations.
Bone Marrow Transplant for AML
BMT is the bone marrow transplant center in India. For patients with intermediate- or high-risk cytogenetics or measurable residual disease (MRD), an allogeneic stem cell transplant provides the best chance of long-term survival. We offer matched sibling donor (MSD), matched unrelated donor (MUD), and haploidentical stem cell transplant for AML. In select pediatric and relapsed cases, cord blood transplant may also be recommended.
As a leading Acute Myeloid Leukemia (AML) center in Hisar, Faridabad, Gurgaon and Mauritius, our transplant outcomes meet international benchmarks.
AML Remission and Post-Transplant Follow-up
Following treatment, MRD status is closely monitored through flow cytometry and molecular tests. Our AML remission treatment includes GVHD management, antifungal and antiviral prophylaxis, nutritional support, and psychological counseling. Our multidisciplinary approach ensures that patients not only survive but thrive post-treatment.
We provide one of the highest AML transplant success rates in the region, owing to our strict infection control protocols, HEPA-filtered transplant rooms, and expert post-transplant care teams.
Advanced AML Therapies and Innovation
We are actively engaged in clinical research and innovation in AML care. BMT Next provides donor lymphocyte infusions (DLI), post-transplant maintenance therapy, and CAR-T therapy access in collaboration with research partners. We specialize in managing refractory AML and relapsed AML using advanced protocols tailored for poor-prognosis patients.
Why Choose BMT Next for AML Treatment in India?
BMT Next stands apart for its unmatched clinical outcomes, affordability, and accessibility. We are known for:
- Best acute myeloid leukemia bone marrow transplant outcomes in North India
- Comprehensive AML care in Gurgaon, Faridabad, Hisar, and Mauritius
- Dedicated AML specialists trained at top institutes
- Affordable AML chemotherapy and transplant packages
- Seamless care coordination for international patients
Need Help?
FAQs
Is acute myeloid leukemia treatment possible without transplant?
Yes, for favorable-risk AML or elderly patients unfit for transplant, chemotherapy with or without targeted therapy can achieve remission.
What is the AML transplant success rate?
With matched donors and early transplant during first remission, success rates range between 50%–70% depending on age, risk factors, and MRD status.
How long does acute myeloid leukemia (AML) treatment take?
Induction chemotherapy usually takes 4–6 weeks. Consolidation or transplant requires another 4–8 weeks. Post-transplant recovery may last several months.
How is acute myeloid leukemia (AML) different from chronic myeloid leukemia (CML)?
AML is acute and aggressive, requiring immediate intensive therapy. CML is a chronic disease often managed long-term with oral targeted drugs like imatinib.
What is acute myeloid leukemia (AML) remission treatment?
It includes post-chemotherapy or post-transplant follow-up, MRD monitoring, immunosuppression tapering, and infection prevention to avoid relapse.
Is acute myeloid leukemia (AML) common in India?
Yes, AML is one of the most common acute leukemias in adults, and its incidence is rising in urban populations.
Can children get AML?
Yes. AML in children and adolescents requires pediatric-specific treatment protocols and is managed by our expert pediatric oncology team.